欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > CytoskeletalSignaling > CCT251545

浏览历史

S83824

CCT251545

MedMol 98%
  • 英文名:
  • CCT251545
  • 别名:
  • CAS号:
  • 1661839-45-7
  • 分子式:
  • C23H24ClN5O
  • 分子量:
  • 421.9225
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
MedMol S83824-2mg 98% ¥470.00元 5 - - - EA 加入购物车
MedMol S83824-5mg 98% ¥860.00元 6 - - - EA 加入购物车
MedMol S83824-10mg 98% ¥1700.00元 5 - - - EA 加入购物车
MedMol S83824-50mg 98% ¥5168.00元 2 - - - EA 加入购物车
源叶(MedMol) S83824-100mg 98% ¥7900.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: CCT251545 是一种有效的口服生物利用型的 WNT 信号抑制剂,在7dF3细胞中的IC50值为5 nM。CCT251545 还可作为选择性化学探针,探讨 CDK8 和 CDK19 在人类疾病中的作用
  • 靶点: CDK8; CDK19; Wnt(in 7dF3 cells):5 nM;Wnt/beta-catenin
  • 体外研究:
    The suppression of the WNT pathway activity by CCT251545 is not unique to a specific cell line, is independent of exogenous WNT pathway stimulation, does not result from destabilization of TCF1 or TCF4, and is not due to interference with the luciferase-based reporter readout. CCT251545 also demonstrates a lack of transporter-mediated efflux and a lack of activity across broad in vitro panels of enzyme, receptor, and ion channel targets
  • 体内研究:
    CCT251545 is a potent small-molecule inhibitor of WNT signaling with good oral pharmacokinetics. We demonstrate inhibition of WNT pathway activity in a solid human tumor xenograft model with evidence for tumor growth inhibition following oral dosing
  • 细胞实验: Cell lines: 7dF3 cells, HEK293 cells, SW480, LS174T, COLO205 human colorectal cancer cells Concentrations: 9.1 μM - 0.068 nM Incubation Time: 2 h, 6 h Method: Taqman Assays. 7dF3 cells are seeded at 20 000 cells/well into 96-well cell culture plates. After overnight incubation the cells are treated with CCT251545 at concentrations ranging from 9.1 μM to 0.068 nM. After 2 or 6 h of incubation, cells are washed with PBS and stored at −80 ℃. Cells are lysed in Cells-to-cDNA II Cell lysis buffer and transferred to PCR plates.
  • 动物实验: Animal Models: Female NMRI mice, Male Wistar rats Dosages: 0.2 mg/kg, 0.5 mg/kg Administration: IV, Oral gavage
  • 参考文献:
    1. Aurélie Mallinger, et al. Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen. J Med Chem. 2015 Feb 26;58(4):1717-35. 2. Trevor Dale, et al. A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease. Nat Chem Biol. 2015 Dec;11(12):973-980.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.37 ml 11.851 ml 23.701 ml
    5 mM 0.474 ml 2.37 ml 4.74 ml
    10 mM 0.237 ml 1.185 ml 2.37 ml
    50 mM 0.047 ml 0.237 ml 0.474 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。